[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of GB002 recombinant peptide inhalation solution in healthy Chinese adult subjects in a randomized, double-blind, placebo-controlled, single and multiple dose escalation
主要目的
评价健康受试者单次/多次吸入不同剂量GB002重组多肽的安全性和耐受性。
次要目的
1 )评价健康受试者单次 / 多次吸入不同剂量 GB002 重组多肽 的 药 代 动 力 学
(Pharmacokinetics,PK,简称药动学)特征;
2)评价健康受试者单次/多次吸入不同剂量GB002重组多肽后的免疫原性。
[Translation] Main purpose
To evaluate the safety and tolerability of GB002 recombinant peptides in healthy subjects after single/multiple inhalation of different doses.
Secondary purpose
1) To evaluate the pharmacokinetic (PK) characteristics of GB002 recombinant peptides in healthy subjects after single/multiple inhalation of different doses;
2) To evaluate the immunogenicity of GB002 recombinant peptides in healthy subjects after single/multiple inhalation of different doses.